Kindly share this postWhatsApp said yesterday it would allow parents to ​create accounts for pre-teens, restricted to messaging ‌and calling, amid rising global concerns about the impact of social ...

The human brain has four distinct turning points where its structure changes, according to a study published in the journal Nature Communications, demonstrating that brain development is not as linear ...

Curatis Holding AG (SIX: CURN) and Neupharma Co., Ltd. (“Neupharma”), a Japanese pharmaceutical company specializing in oncology, immunology, pulmonology and cardiology disorders, today announce an ...

A new study suggests that growing up in poverty accelerates biological development. For adolescent girls, this early onset of puberty provides a pathway linking financial hardship to increased anxiety ...

More early-stage data show the drug, called salanersen, appeared to have positive effects on neurodegeneration and motor function in patients previously treated with Novartis' Zolgensma.

JACKSON, MI - March 11, 2026 - PRESSADVANTAGE - Nu-Ice Blasting™, a U.S.-based, veteran-owned manufacturer of dry ice ...

Plan International Ghana has officially launched Phase 2 of its Integrated Package for Sustainable Community Development (IPADEV), aimed at improving water, ...

Good morning, everyone. My name is Etzer Darout, Senior Biotech Analyst at Barclays. My pleasure to have Incyte joining us today, day 2 of our conference. With me, I have Bill Meury, President and ...

The 2025 Interdisciplinary Research Grant (IRG) for Convergent Innovation is designed to contribute to CUNY’s goal of amplifying the quantity and quality of engaged public impact research and ...

For the artificial intelligence expert, the greatest challenge is not which technology we use, but which human capacities we ...

The FDA expands Palynziq approval to include pediatric patients aged 12 years and older with phenylketonuria and uncontrolled blood Phe levels.

Biogen Inc. presented additional results from the Phase 1b study of salanersen, an investigational novel antisense oligonucleotide (ASO) given once a year for spinal muscular atrophy (SMA), at the ...